Table 1.

Effect of antileukemia CTL lines on the in vitro growth of clonogenic progenitor cells

Patient 2Patient 4
BFU-ECFU-GMCFU-GEMMBFU-ECFU-GMCFU-GEMM
Experiment 1 
  Control 36 30 99 80 
 PBL, 4 h 38 28 81 68 1  
 PBL, 7 h 33 24 100 79 2  
 CTL3, 4 h 29 32 ND ND ND  
 CTL3, 7 h 30 24 86 70 1  
 CTL4, 4 h 33 25 79 71 2  
 CTL4, 7 h 29 25 79 74 1  
Experiment 2 
  Control 33 52 105 95 3  
 CTL allo, 4 h 10 17 29 19 0  
 CTL allo, 7 h 11 12 
Patient 2Patient 4
BFU-ECFU-GMCFU-GEMMBFU-ECFU-GMCFU-GEMM
Experiment 1 
  Control 36 30 99 80 
 PBL, 4 h 38 28 81 68 1  
 PBL, 7 h 33 24 100 79 2  
 CTL3, 4 h 29 32 ND ND ND  
 CTL3, 7 h 30 24 86 70 1  
 CTL4, 4 h 33 25 79 71 2  
 CTL4, 7 h 29 25 79 74 1  
Experiment 2 
  Control 33 52 105 95 3  
 CTL allo, 4 h 10 17 29 19 0  
 CTL allo, 7 h 11 12 

LDBMCs were incubated in RPMI 1640 and 10% FCS in the presence of PBMCs or CTLs at a ratio of 1:3, respectively. After 4- and 7-hour incubations at 37°C, cells were washed and plated in methylcellulose in a classical clonogenic assay. Numbers represent the mean colony number of a clonogenic assay performed in duplicate.

CTL3 indicates CTL obtained after 3rd stimulation; CTL4, CTL obtained after 4th stimulation; CTL allo, CTL obtained after induction of a healthy volunteer's PBMCs with autologous DCs pulsed with irradiated patient 2 or patient 4 BMRCs, respectively; ND, not done.

or Create an Account

Close Modal
Close Modal